Sanofi and Regeneron Announce CHMP Recommends European Approval of Praluent alirocumab for the Treatment of Hypercholesterolemia

Sanofi and Regeneron Announce CHMP Recommends European Approval of Praluent alirocumab for the Treatment of Hypercholesterolemia Paris and Tarrytown New York July 24 2015 Sanofi and Regeneron Pharmaceuticals Inc. announced today that the European Me...